NALLY MICHAEL (Chief Executive Officer) purchased 3.6% of their position (20K shares) of GENERATE BIOMEDICINES, INC. on the open market
Open‑market purchase worth $240.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/6/2026ACC: 0001193125-26-096799
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+20K
Net shares
Net buyer
$240.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$12.00
Trade value
$240K
% of position
3.6%
3/4/2026
552.71K→572.71K
Total
Net shares
+20K
Net value
$240K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | P · Purchase | +20K | $12.00 | $240K | 3.6% | 552.71K | 572.71K |
| Total | +20K | $240K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned999.79K
Common Stock
IndirectShares owned1.32M
Total
2.32M indirect2.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 999.79K | Indirect |
| Common Stock | 1.32M | Indirect |
| Total | 2.32M | 2.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported